Page last updated: 2024-10-27

flecainide and ST Elevated Myocardial Infarction

flecainide has been researched along with ST Elevated Myocardial Infarction in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shen, X1
Tan, BYQ1
Sia, CH1
Lee, JSW1
Dalakoti, M1
Wang, K1
Lim, DYZ1
Sng, GGR1
Lee, ECY1
Chow, W1
Kwan, CKW1
Wang, LK1
Tan, BY1
Lim, PCY1
Chua, KCM1
Ho, KL1
Lim, ETS1
Ching, CK1
Teo, WS1
Chua, TSJ1
Tan, RS1
Yeo, TJ1
Chong, DTT1

Other Studies

1 other study available for flecainide and ST Elevated Myocardial Infarction

ArticleYear
Prevalence of Brugada Syndrome in a Large Population of Young Singaporean Men.
    Circulation, 2020, 01-14, Volume: 141, Issue:2

    Topics: Adolescent; Brugada Syndrome; Electrocardiography; Flecainide; Humans; Male; Prevalence; Singapore;

2020